Telomir Pharmaceuticals (TELO) Invested Capital (2023 - 2026)
Telomir Pharmaceuticals (TELO) posted Invested Capital of $101000.0 for Q4 2023.
Telomir Pharmaceuticals (TELO) Invested Capital (2023 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Invested Capital for 1 years, with the latest figure at $101000.0 in Q4 2023.
- Quarterly Invested Capital changed N/A year-over-year to $101000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $101000.0 (changed N/A YoY) and the FY2023 annual result came in at $101000.0, changed N/A from the prior year.
- Invested Capital steadied at $101000.0 in Q4 2023 per TELO's latest filing.
- Over five years, Invested Capital peaked at $101000.0 in Q4 2023 and troughed at $101000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Telomir Pharmaceuticals | 69.05 Mn | 69.05 Mn | - | 136,372.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136,372.00 |
| Dec 31, 2023 | 101,000.00 |